2023 AASLD Foundation Abstract Awardees
American Association for the Study of Liver Diseases (AASLD) Foundation Abstract Awards recognize excellence in liver research and promote the professional development of junior investigators. These awards offer the career-shaping experience of presenting outstanding science at a major, international hepatology meeting by providing travel support to defray costs to attend The Liver Meeting® or Digestive Disease Week®.
Congratulations to the 83 rising leaders in liver research who received an Abstract Award in 2023.
On This Page
The Liver Meeting® 2023 Abstract Awards
DR. LEONARD B. SEEFF AWARD FOR OUTSTANDING RESEARCH BY AN EARLY CAREER INVESTIGATOR
Jing Zeng, MD
Virginia Commonwealth University, United States
ALTERED SMALL AND LARGE INTESTINAL GENE EXPRESSION RELATED TO OXYGEN CONSUMPTION AND INFLAMMATION IN PATIENTS WITH CIRRHOSIS COULD CONTRIBUTE TOWARDS DYSBIOSIS AND LIVER DISEASE PROGRESSION
INTERNATIONAL EARLY CAREER INVESTIGATOR AWARD PRESENTED IN HONOR OF PROFESSOR C.Y. KIM
Won-Mook Choi, MD, PhD
Asan Medical Center, South Korea
NON-LINEAR ASSOCIATION OF BASELINE VIRAL LOAD WITH ON-TREATMENT HEPATOCELLULAR CARCINOMA RISK IN CHRONIC HEPATITIS B
THE PROFESSOR MARGIT HAMOSH TRAVEL AWARD
Rex Wan-Hin Hui, MBBS, MRes(Med), MRCP
The University of Hong Kong, Hong Kong
RECURR-NET, A MULTIPHASIC DEEP LEARNING MODEL, IS SUPERIOR TO MICROVASCULAR INVASION IN PREDICTING HEPATOCELLULAR CARCINOMA RECURRENCE AFTER CURATIVE SURGERY: RESULTS FROM INTERNAL VALIDATION AND EXTERNAL TESTING
THE PROFESSOR MINDIE H. NGUYEN AWARD FOR OUTSTANDING CLINICAL RESEARCH BY EARLY CAREER INVESTIGATORS
You Deng, MD, PhD
Center of Liver Diseases, Beijing Ditan Hospital, Capital Medical University, China
STABLE RECOMPENSATION IN ENTECAVIR-TREATED HEPATITIS B PATIENTS WITH DECOMPENSATED CIRRHOSIS
Yu Rim Lee, MD, PhD
Kyungpook National University, Chilgok Hospital, South Korea
AN ARTIFICIAL INTELLIGENCE MODEL FOR PREDICTION OF HEPATOCELLULAR CARCINOMA DEVELOPMENT AFTER ORAL ANTIVIRAL THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C
Leow Yong Wen, MBBS
University of Malaya, Malaysia
VALIDATION OF LIVERFAST-GP+ (GP+) AS A NON-INVASIVE TEST FOR RISK STRATIFICATION FOR PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD): SINGLE-CENTRE STUDY USING LIVER BIOPSY AS REFERENCE STANDARD
Froylan David Martinez-Sanchez, MD
Hospital General Dr. Manuel Gea González, Mexico
FACTORS ASSOCIATED WITH ADVANCED LIVER FIBROSIS IN A POPULATION WITH TYPE 2 DIABETES: A 5-YEARS RETROSPECTIVE COHORT STUDY IN MEXICO CITY
Hiroko Setoyama, MD, PhD
Kumamoto University, Japan
NATIONWIDE SURVEY OF THE IMPACT OF COVID-19 ON THE CLINICAL PRACTICE AND CARE OF PATIENTS WITH LIVER DISEASE IN JAPAN
Kessarin Thanapirom, MD
Chulalongkorn University Hospital, Thailand
THE PREDICTIVE SCORE FOR SCREENING METABOLIC ASSOCIATED FATTY LIVER DISEASE WITH SIGNIFICANT FIBROSIS IN THE PRIMARY CARE SETTING: A MULTICENTER STUDY
Tsubasa Tsutsumi, MD, PhD
Kurume University School of Medicine, Japan
HEPATIC LOBULAR INFLAMMATION IS THE MOST IMPACTED PROGNOSTIC FACTOR RATHER THAN FIBROSIS IN PATIENTS WITH BIOPSY-PROVEN MASLD: MULTI-CENTER STUDY
NORTHERN LIGHTS CANADIAN LEGACY TRAVEL AWARD
Molly McDonald, RN
University Health Network, Canada
EVALUATION OF SAFETY OF A NURSE-LED PARACENTESIS MODEL FOR PATIENTS WITH DECOMPENSATED LIVER DISEASE IN AMBULATORY CARE: A RETROSPECTIVE REVIEW
Toshifumi Yodoshi, MD, PhD
Hospital for Sick Children (SickKids), Canada
ANONYMOUS LIVING LIVER DONATION IMPROVES ACCESS FOR MEDICALLY UNDERSERVED CHILDREN IN NEED OF LIVER TRANSPLANTATION: THE CANADIAN EXPERIENCE
THE ROSALYN AND LEO FRIED MEMORIAL TRAVEL AWARD
Shoham Dabbah
Tel Aviv University, Israel
IMPLEMENTATION OF MACHINE LEARNING ALGORITHMS FOR THE SCREENING OF ADVANCED LIVER FIBROSIS AMONG NON-ALCOHOLIC FATTY LIVER DISEASE PATIENTS: AN IN-DEPTH EXPLANATORY MODELING
Riham Soliman, MD
Egyptian Liver Research Institute and Hospital (ELRIAH), Egypt
VERY LOW DETECTION LIMIT FOR A NOVEL POINT OF CARE TEST OF HCV VIREMIA USING TEMPERATURE-SENSITIVE SMART POLYMER TECHNOLOGY
PSC PARTNERS SEEKING A CURE TRAVEL AWARD
Melinda Wang, MD, MHS
University of California, San Francisco, United States
NETWORK ANALYSIS OF SYMPTOMS EXPERIENCED BY PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS
ADVANCED PRACTICE PROVIDER AWARD
Pauline Dundas, RN, BSc, PGDip, MSc
NHS Grampian, United Kingdom
NURSE LED CLINIC FOR PATIENTS WITH DECOMPENSATED LIVER DISEASE
William A. Murphy, PharmD
University of North Carolina Eshelman School of Pharmacy, United States
BILE SALT EFFLUX PUMP (BSEP) MEMBRANE-LOCALIZED ZONAL ABUNDANCE IN HUMAN LIVER TISSUE FROM PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)
EARLY CAREER INVESTIGATOR AWARD IN BASIC SCIENCE
Joseph Brancale
Yale School of Medicine, United States
ELUCIDATING THE MECHANISMS OF KIF12-MEDIATED HIGH GGT CHOLESTASIS
Ashley Calder, PhD
University of Michigan, United States
DEFINING THE WNT SIGNALING LANDSCAPE OF THE EXTRAHEPATIC BILE DUCT AT HOMEOSTASIS AND IN OBSTRUCTIVE CHOLANGIOPATHY
Yiyu Fan, BM, MSc, PhD student
University of Birmingham, United Kingdom
HEPATOCYTE DELETION OF REGULATORY T CELLS BY ENCLYSIS IS INCREASED IN AUTOIMMUNE HEPATITIS COMPARED TO MASH AND CAN BE TOGGLED BY PPARΑ AGONISTS AND ANTAGONISTS.
Chhavi Goel, PhD
University of Pittsburgh, United States
CONDITIONAL LOSS OF Β-CATENIN LOWERS TOXIC BILE-INDUCED HEPATIC INJURY AND IMPROVES CHOLESTATIC OUTCOME IN MURINE MODEL
Jain Jeong, PhD
Yale School of Medicine, United States
LIVER LYMPHANGIOGENESIS MITIGATES THE PROGRESSION OF FIBROSIS
Hyun Se (Daniel) Kim Lee
Mayo Clinic Rochester, United States
GENETIC ABLATION OF CD4 T CELLS IN MICE ATTENUATES LIVER INJURY, INFLAMMATION,AND FIBROSIS IN NONALCOHOLIC STEATOHEPATITIS
Yekaterina Krutsenko, BS
University of Pittsburgh, United States
DUAL LOSS OF Β- AND Γ-CATENINS FROM CHOLANGIOCYTES LEADS TO ACUTE CHOLESTASIS AND MORTALITY DUE TO HEPATOBILIARY INJURY AND MALADAPTATION AS REVEALED BY SINGLE-NUCLEUS RNA SEQUENCING
Jialin Liao, MD
Nanfang Hospital, Southern Medical University, China
SLC1A5 REGULATES LIPID METABOLISM AND FORMS AN IMMUNOSUPPRESSIVE TME IN HCC
Astha Malik, PhD
Cincinnati Children's Hospital Medical Center, United States
FARNESOID X RECEPTOR (FXR) CONTROLS CHOLANGIOCYTE INJURY RESPONSES IN EXPERIMENTAL BILIARY ATRESIA
Anne Olbrich, PhD
University Medical Center Leipzig, Germany
CHARACTERIZATION OF THE ANTIBODY REPERTOIRE AGAINST mAChR3 IN PATIENTS WITH PBC AND PSC
Oleksandr Petrenko, MD
Medical University of Vienna, Austria
DECIPHERING OF HEPATIC SINGLE-CELL INTERACTOME IN PRIMARY SCLEROSING CHOLANGITIS
Srinivas Pittala, PhD
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), United States
ACTIVATION OF RECEPTOR-MEDIATED G12 SIGNALING HAS PRONOUNCED EFFECTS ON HEPATIC GLUCOSE FLUXES
Chinmay Raut, BS
University of Michigan at Ann Arbor, United States
MULTI-ANCESTRY WHOLE GENOME SEQUENCING (WGS) AND META-ANALYSIS TO IDENTIFY LOCI ASSOCIATED WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
Milad Rezvani, MD, PhD
Charité University Medicine Berlin, Germany
MODELING HEPATO-HEMATOPOIETIC DEVELOPMENT IN FETAL LIVER ORGANOIDS FROM HUMAN PLURIPOTENT STEM CELLS
Hongxue Shi, PhD
Columbia University Irving Medical Center, United States
LOSS OF KUPFFER CELL TIM4-DEPENDENT EFFEROCYTOSIS PROMOTES LIVER FIBROSIS IN NONALCOHOLIC STEATOHEPATITIS
Lucía Valenzuela-Pérez, DVM, PhD
Mayo Clinic Rochester, United States
SINGLE-CELL ANALYSES IDENTIFY ENRICHMENT OF TH1 CELLS IN MURINE NONALCOHOLIC STEATOHEPATITIS
Han Wang, MD, PhD
Tongji Hospital, Huazhong University of Science and Technology, China
NEUTROPHIL EXTRACELLULAR TRAPS PROMOTE AUTOIMMUNE HEPATITIS THROUGH INHIBITING THE SUICIDE OF CD8+ T CELLS
Feng Wang, PhD
Chungbuk National University, South Korea
UBC13 PROTECTS AGAINST DEFECTIVE MITOPHAGY IN NON-ALCOHOLIC FATTY LIVER DISEASE BY PROMOTING K63-LINKED P62 UBIQUITINATION
Xiaochun Yang, PhD
Feinstein Institutes for Medical Research, United States
TARGETING NASH AND HCC THROUGH DIVERSION OF TGF-BETA SIGNALING
Josephine Zhang, BS
Stanford University, United States
SINGLE-NUCLEI TARGETED DNA SEQUENCING REVEALS PATTERNS OF SELECTIVE CLONAL EVOLUTION DURING HEPATOCELLULAR CARCINOMA (HCC) PROGRESSION
EARLY CAREER INVESTIGATOR AWARD IN CLINICAL/TRANSLATIONAL SCIENCE
Manasa Alla, MD, DM
Institute of Liver and Biliary Sciences, India
SMALL FREQUENT PARACENTESIS USING AN INDWELLING CATHETER IS SAFE AND MORE EFFECTIVE AS COMPARED WITH REPEATED LARGE VOLUME PARACENTESIS IN CIRRHOTIC PATIENTS WITH REFRACTORY ASCITES (I-CARE)
Sagnik Biswas, MD, DM
All India Institute of Medical Sciences, India
SERIAL ENDOSCOPIC INJECTION SCLEROTHERAPY WITH N BUTYL CYANOACRYLATE GLUE VERSUS RADIOLOGICAL INTERVENTION FOR SECONDARY PROPHYLAXIS OF GASTRIC VARICEAL HEMORRHAGE IN PATIENTS WITH LIVER CIRRHOSIS (CRISP-GV): A RANDOMIZED CONTROLLED TRIAL
Fernando Bril, MD
University of Alabama at Birmingham, United States
ADIPOSE TISSUE INSULIN RESISTANCE AFFECTS LIVER MITOCHONDRIAL FUNCTION INDEPENDENTLY OF LIVER FAT ACCUMULATION
Noemi Cabre, PhD
University of California, San Diego, United States
INTESTINAL ENDOGENOUS RETROVIRUSES PROMOTE ETHANOL-INDUCED LIVER DISEASE INMICE
Ainhoa Ferret-Miñana, MS
Institute for Bioengineering of Catalonia, Spain
A HUMAN THREE-DIMENSIONAL MULTICELLULAR LIVER MODEL FOR PREDICTING DRUG EFFICACY IN CHRONIC LIVER DISEASE
Soumita Ghosh, PhD
University of Toronto, Canada
CLEVER-LG (CELL-FREE DNA METHYLATION WITH CLINICAL VARIABLES) FOR EARLY RECOGNITION OF LIVER GRAFT PATHOLOGY USING MACHINE LEARNING
Priti Jain, DM, DNB, MD
Institute of Liver and Biliary Sciences, India
COMPARISON OF BOLUS VERSUS CONTINUOUS INFUSION OF TERLIPRESSIN IN CIRRHOTIC PATIENTS WITH SEPTIC SHOCK: A RANDOMIZED CONTROLLED TRIAL (NCT 04819568)
Georgia Sofia Karachaliou, MD, MSc
Duke University Medical Center, United States
AN AGE-STATIN INTERPLAY IN PREVENTING THE DEVELOPMENT OF CIRRHOSIS INA 10-YEAR COHORT OF PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE(NAFLD)
Arunkumar Krishnan, MBBS
Atrium Health Levine Cancer Institute, United States
BARIATRIC SURGERY AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE, OBESITY, AND CARDIOVASCULAR DISEASE: A POPULATION-BASED RETROSPECTIVE COHORT STUDY
Jonathan Li
UCSF School of Medicine, United States
A NOVEL HCC WAITLIST DROPOUT SCORE: BIOMARKER INTEGRATED DROPOUT GRADIENT ESTIMATION (BRIDGE)
Diana Nakib
University Health Network, University of Toronto, Canada
SINGLE CELL ATLAS OF LIVING DONOR LIVER BIOPSIES REVEALS HEPATO-INFLAMMATORY GENE ACTIVATION AND T CELL RECRUITMENT IN THE NEUROLOGICALLY DECEASED DONOR LIVER
David Prince, MBBS, MPH, MHM, FRACP
Centenary institute, Australia
THE LIVER TOOLKIT – AN INNOVATIVE INFORMATION TECHONOLOGY SOLUTION TO SCREEN PATIENTS IN GENERAL PRACTICE FOR UNDIAGNOSED CIRRHOSIS
Simon Schophaus
RWTH Aachen University, Germany
MACHINE LEARNING PREDICTS DIETARY PATTERNS ASSOCIATED WITH FATTY LIVER DISEASE PROTECTION
Anandini Suri, MD
Saint Louis University, United States
Z POLYMER LEVELS AND FACTORS AFFECTING INCREASED LIVER FIBROSIS ARE ASSOCIATED WITH FUTURE SEVERE LIVER DISEASE OUTCOMES IN A PROSPECTIVE COHORT OF ADULTS WITH ALPHA-1-ANTITRYPSIN DEFICIENCY
Nikolaj Torp, MD
Odense University Hospital, Denmark
HIGH DOSES OF ALBUMIN INCREASES MORTALITY AND COMPLICATIONS IN TERLIPRESSIN TREATED PATIENTS WITH CIRRHOSIS: INSIGHTS FROM THE ATTIRE TRIAL
Harshita Tripathi, PhD
Institute of Liver and Biliary Sciences, India
SATURATED FAT FAVORABLY ALTERS THE GUT MICROBIOTA AND IMPROVES SURVIVAL IN PATIENTS WITH SEVERE ALCOHOLIC HEPATITIS: A RANDOMIZED CONTROLLED TRIAL
Shannon M. Vandriel, BSc
The Hospital for Sick Children, Canada
SURGICAL BILIARY DIVERSION IS ASSOCIATED WITH AN INCREASED RISK OF LIVER TRANSPLANTATION OR DEATH IN ALAGILLE SYNDROME
Mohit Varshney, MD, DM
Institute of Liver and Biliary Sciences, India
ANALYZING NEW ONSET HEPATIC DECOMPENSATION AND LONG TERM ABSTINENCE/CRAVING IN PATIENTS WITH ALCOHOL ASSOCIATED LIVER DISEASES(AALD): A DOUBLE BLIND RANDOMIZED CONTROL TRIAL (RCT) FOR EFFECTIVENESS OF SELF ADMINISTERED 12 WEEKS 50 MG ORAL NALTREXONE VERSU
Mara Sophie Vell
University Hospital Rwth Aachen, Germany
MAXIMIZING THE BENEFITS OF STATIN THERAPY FOR LIVER DISEASE PREVENTION: TARGETING PATIENTS WITH UNMET STATIN THERAPY NEEDS
Yoshimi Yukawa-Muto, MD, PhD
Osaka Metropolitan University Graduate School of Medicine, Japan
IDENTIFICATION AND CHARACTERIZATION OF THE GUT MICROBIAL SPECIES INVOLVED IN HEPATIC ENCEPHALOPATHY FROM THE ANALYSIS OF PATIENTS ADMINISTERED RIFAXIMIN
EARLY CAREER INVESTIGATOR AWARD IN HEALTHCARE DISPARITIES
Hirsh Elhence, BA
Keck School of Medicine of USC, United States
CHARACTERISTICS AND OUTCOMES OF TRANSGENDER PATIENTS WITH CIRRHOSIS: A NATIONAL COHORT STUDY
Alan L. Hutchison, MD, PhD
University of Chicago, United States
GEOGRAPHIC OPPORTUNITIES FOR GROWTH IN THE TRANSPLANT HEPATOLOGY TRAINING WORKFORCE
Yu Ri Im, MB BChir BSc Hons
University of Oxford, United Kingdom
THE EFFICACY OF ANTIVIRAL THERAPY AT PREVENTING CLINICAL OUTCOMES IN HBV-INFECTED PEOPLE AT DIFFERENT BASELINE VIRAL LOAD AND ALT LEVELS: A GLOBAL SYSTEMATIC REVIEW & META-ANALYSIS
Ranganath G. Kathawate, BS
Wayne State University School of Medicine, United States
EARLY HOSPITALIZATION FOR ACUTE KIDNEY INJURY AFTER LIVER TRANSPLANTATION IS AN INDEPENDENT RISK FACTOR FOR DE NOVO END-STAGE RENAL DISEASE
Basile Njei, MD, MPH, PhD
Yale University, United States
MORTALITY, HEPATIC DECOMPENSATION, AND CARDIOVASCULAR OUTCOMES IN LEAN VS. NON-LEAN MASH CIRRHOSIS: A VETERANS AFFAIRS COHORT STUDY
FELLOW RESEARCH AWARD
Sai Santosh Babu Komakula, PhD
University of Illinois at Chicago, United States
OVEREXPRESSION OF OSTEOPONTIN (SPP1) IN BILIARY EPITHELIAL CELLS CAUSES DUCTULAR REACTION
INTERNATIONAL EARLY CAREER INVESTIGATOR AWARD
Aylin Coskun, MD
Istanbul Faculty of Medicine, Türkiye
HYPERLIPIDEMIA, ATHEROSCLEROSIS AND HEPATOSTEATOSIS IN PRIMARY BILIARY CHOLANGITIS: WHAT IS THE RISK?
Muhammed Khaled Elhadi Elfaituri, MBBCh, MSc
University of Tripoli, Libya
ENHANCING LAPAROSCOPIC HEPATECTOMY OUTCOMES IN LIVER CANCER WITH INDOCYANINE GREEN FLUORESCENCE IMAGING: A SYSTEMATIC REVIEW AND META-ANALYSIS
Daniel Ernest L. Florendo, MD
Philippine General Hospital, Philippines
SURGICAL MANIFESTATIONS OF HEPATOBILIARYPANCREATIC TUBERCULOSIS
Huu Huy Nguyen, MS
University Medical Center of HCMC, Vietnam
PREVALENCE OF AUTOANTIBODIES IN PATIENTS WITH AUTOIMMUNE HEPATITIS AT UNIVERSITY MEDICAL CENTER HCMC
Madhumita Premkumar, MD, DM
Postgraduate Institute of Medical Education and Research, India
RECOMPENSATION OF CHRONIC HEPATITIS C-RELATED DECOMPENSATED CIRRHOSISFOLLOWING DIRECT-ACTING ANTIVIRAL THERAPY: REAL-WORLD DATA FROM THE PUNJABHCV ELIMINATION MODEL
LIVER TRANSPLANT AND/OR HEPATOBILIARY SURGERY FELLOW AWARD
Stephen J. Hartman, MD
Cincinnati Children's Hospital Medical Center, United States
RHESUS ROTAVIRUS INFECTION OF PLASMACYTOID DENDRITIC CELLS DRIVES NATURAL KILLER CELL ACTIVATION LEADING TO BILE DUCT OBSTRUCTION
Kenji Okumura, MD
Westchester Medical Center / New York Medical College, United States
IMPACT OF DONOR CORONARY ARTERY DISEASE ON PATIENT AND GRAFT SURVIVAL AMONG LIVER TRANSPLANT RECIPIENTS IN THE UNITED STATES
PEDIATRIC RESEARCH AWARD
Chaowapong Jarasvaraparn, MD
Riley Hospital for Children/Indiana University, United States
THE SIGNIFICANT ASSOCIATION BETWEEN PNPLA3 G ALLELE AND ADVANCED FIBROSIS IN CHILDREN WITH NAFLD IS FURTHER INFLUENCED BY BMI AND type2 DIABETES
RESIDENT RESEARCH AWARD
Roy Wang, MD
Hospital of the University of Pennsylvania, United States
TRENDS IN UTILIZATION AND POST-TRANSPLANT OUTCOMES IN COVID-19 POSITIVE DECEASED DONOR LIVER TRANSPLANTATION
STUDENT RESEARCH AWARD
Helen Ye Rim Huang, MBChB
Perelman School of Medicine, University of Pennsylvania, United States
DEEP PHENOTYPING OF TM6SF2 TO CHARACTERIZE HEPATIC STEATOSIS, PLASMA LIPID TRAITS, AND METABOLIC RISK FACTORS USING A GENOME-FIRST APPROACH
Digestive Disease Week® 2023 Abstract Awards
Fellow Abstract Award in Healthcare Disparities Research
Maria J. Duarte, MD
University of California, San Francisco, United States
GUT MICROBIAL TRANSLOCATION IS ASSOCIATED WITH ELEVATED FAST SCORE IN WOMEN LIVING WITH AND WITHOUT HIV
Fellow Abstract Award
Priyanka Banerjee, PhD
Texas A&M Health Science Center, United States
SARS-COV-2 INFECTION MEDIATED CYTOKINE STORM PROMOTES ENDOTHELIAL TO MESENCHYMAL TRANSITION (ENDMT) IN LYMPHATIC ENDOTHELIAL CELLS (LECS) AND CONTRIBUTE TO TUMOR PROGRESSION IN CHOLANGIOCARCINOMA (CCA)
Chinmay Bera, MD
University of Toronto, Canada
THE UTILITY OF AMAP SCORE IN PREDICTING HEPATOCELLULAR CARCINOMA RISK IN PATIENTS WITH ADVANCED NON-ALCOHOLIC FATTY LIVER DISEASE
Apaar Dadlani, MBBS
Baylor College of Medicine, United States
HIGH DOSE ALBUMIN IN PATIENTS WITH CIRRHOSIS AND REFRACTORY ASCITES DECREASES FREQUENCY OF PARACENTESES, AND THE VOLUME OF FLUID REMOVED
Nathan G. Kim, MD, MS
University of California, San Francisco, United States
RADIOEMBOLIZATION COMPARED TO CHEMOEMBOLIZATION AS FIRST LOCOREGIONAL TREATMENT IS ASSOCIATED WITH DECREASED LIVER TRANSPLANT WAITLIST DROPOUT FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA
Lin Kui, PhD
University of California, San Diego, United States
YKL-40 REGULATES NEUTROPHILS RECRUITMENT VIA NLRP3 INFLAMMASOME DURING LIVER INFLAMMATION
Aalam Sohal, MD
Liver Institute Northwest, United States
HEPATIC RETICULOENDOTHELIAL SYSTEM CELL IRON DEPOSITION IS INDEPENDENTLY ASSOCIATED WITH ADVANCED FIBROSIS IN NASH: ANALYSIS OF 2833 PATIENTS FROM THE NASH-CRN
Prashanth Thevkar Nagesh, PhD
Beth Israel Deaconess Medical Center, Harvard Medical School, United States
IN VIVO BRUTON’S TYROSINE KINASE (BTK) INHIBITION ATTENUATES ALCOHOL ASSOCIATED LIVER DISEASE BY REGULATING GRANULOPOIESIS INVOLVING CD84 (SLAM5)
Patrick Twohig, MD, MPH
University of Nebraska Medical Center, United States
USE OF ULTRASOUND SHEAR-WAVE ELASTOGRAPHY TO ASSESS THE PREVALENCE OF HEPATIC STEATOSIS & FIBROSIS IN TURNER SYNDROME: A PROSPECTIVE CASE-CONTROL STUDY
Yu Jun Wong, MD, MCI, FRCP, FAMS
Changi General Hospital, Singapore
HIGH COMPLIANCE OF AASLD CIRRHOSIS QUALITY MEASURES IS ASSOCIATED WITH IMPROVED OUTCOMES IN CIRRHOSIS WITH ACUTE VARICEAL BLEEDING: SINGAPORE NATIONWIDE AUDIT
Jing Zeng, MD
Virginia Commonwealth University, United States
IDENTIFICATION OF POTENTIAL EXOSOMAL MICRORNAS ASSOCIATED WITH CHOLESTATIC LIVER INJURY IN MDR2-/- MICE
